TiO x (OH) 4–2 x Nanosheets with Catalytic Antioxidative Activity Alleviate Oxidative Injury in Diabetic Cardiomyopathy
Journal of the American Chemical Society · 2025
DOI: 10.1021/jacs.4c18026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2025. Verfasst von Yufan Yao und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences; Research…. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, Antioxidants, Oxidative Stress, Nanostructures. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Chinese Academy of Medical Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
Diabetic cardiomyopathy (DCM) is one of the most lethal complications of diabetes and is induced by the overproduction of reactive oxygen species (ROS) in cardiomyocytes due to sustained high glucose levels, leading to cardiac oxidative damage and final sudden death. Drugs and antioxidants currently applied to the clinical therapy of DCM fail to scavenge ROS efficiently, resulting in compromised therapeutic efficacy. Herein, a nanocatalytic antioxidative therapeutic strategy is proposed for DCM treatment. A two-dimensional TiOx(OH)4-2x nanosheet platform has been constructed with efficient ROS-scavenging activity, which can catalyze antioxidation reaction through redox cycling between TiIV/TiIII accompanied by inner-sphere two-electron transfer. Cellular experiments demonstrate that the TiOx(OH)4-2x nanosheet can not only protect cardiomyocytes from oxidative damage induced by a high glucose environment but also alleviate inflammation to further protect cardiomyocytes from inflammatory injury. The in vivo animal model confirms that the nanosheet alleviates myocardial oxidative injury and recovers cardiac function. Such a nanocatalytic antioxidation strategy is expected to provide a feasible approach for treating DCM and other cardiovascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences; Research Unit of Nanocatalytic Medicine in Specific Therapy for Serious Diseas…
- Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing 100049, P. R. China.
ORCID-Profile: Bowen Yang, Jianlin Shi
Förderung
- National Key Research and Development Program of China
- Chinese Academy of Medical Sciences
- National Natural Science Foundation of China
- Shanghai Rising-Star Program
Zitieren
APA
Yao, Y., Yang, B., & Shi, J. (2025). TiO x (OH) 4–2 x Nanosheets with Catalytic Antioxidative Activity Alleviate Oxidative Injury in Diabetic Cardiomyopathy. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.4c18026
Vancouver
Yao Y, Yang B, Shi J. TiO x (OH) 4–2 x Nanosheets with Catalytic Antioxidative Activity Alleviate Oxidative Injury in Diabetic Cardiomyopathy. Journal of the American Chemical Society. 2025. doi:10.1021/jacs.4c18026
BibTeX
@article{Yao2025,
author = {Yao, Yufan and Yang, Bowen and Shi, Jianlin},
title = {TiO x (OH) 4–2 x Nanosheets with Catalytic Antioxidative Activity Alleviate Oxidative Injury in Diabetic Cardiomyopathy},
journal = {Journal of the American Chemical Society},
year = {2025},
doi = {10.1021/jacs.4c18026}
}
EUVIMED